Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$51.61

-0.03 (-0.06%)

07:11
11/06/18
11/06
07:11
11/06/18
07:11

Ionis Pharmaceuticals reports Q3 EPS (3c), consensus (16c)

Reports Q3 revenue $145M, consensus $152.68M.

  • 06

    Nov

  • 27

    Nov

IONS Ionis Pharmaceuticals
$51.61

-0.03 (-0.06%)

10/03/18
MSCO
10/03/18
NO CHANGE
Target $45
MSCO
Equal Weight
Ionis most likely gets Tegsedi approval with black box, says Morgan Stanley
Morgan Stanley analyst David Lebowitz laid out three potential scenarios for the upcoming FDA approval decision about Ionis Pharmaceuticals' Tegsedi, which is scheduled to come on or before October 6. If the FDA were to issue a complete response letter, or CRL, and prevent on-time launch, Lebowitz sees greater than 20% downside for the shares, though he puts the probability of this occurring at 40%. If Tegsedi is approved with a black box safety warning, which he sees as the most likely scenario with odds he pegs at 45%, Lebowitz sees the stock trading up or down about 5%. If Tegsedi is approved with a "clean" label it would lead to a steeper ramp in revenue and Lebowitz sees 20% or more upside to the stock in this scenario, though he puts the odds at just 15%. He maintains an Equal Weight rating on Ionis shares ahead of the PDUFA with a $45 price target.
10/07/18
PIPR
10/07/18
NO CHANGE
Target $160
PIPR
Overweight
Alnylam's Onpattro highly efficacious, safer than competitor, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff notes that Ionis Pharmaceuticals (IONS) announced FDA approval of TEGSEDI for treatment of hATTR polyneuropathy. The analyst also points out that the label includes a Black Box warning for thrombocytopenia and glomerulonephritis requiring every 2-week monitoring, and will be marketed by Ionis subsidiary Akcea (AKCA) with a Risk Evaluation and Mitigation Strategy. TEGSEDI is administered subcutaneously every week versus Alnylam's (ANLY) ONPATTRO intravenously every 3 weeks with steroids, he adds. Tenthoff believes that ONPATTRO appears safer and highly efficacious, and should win out. The analyst reiterates an Overweight rating and $160 price target on Alnylam shares.
10/08/18
CANT
10/08/18
INITIATION
Target $135
CANT
Overweight
Cantor reiterates Overweight on Alnylam after Akcea, Ionis win approval
Cantor Fitzgerald analyst Alethia Young reiterates an Overweight rating on Alnylam Pharmaceuticals (ALNY) with a $135 price target after the FDA approved Tegsedi, to be marketed by Akcea Therapeutics (AKCA). The analyst says that while the approval introduces another competitor to the market, she still expects Alnylam's Onpattroto be able to take significant share in the polyneuropathy hATTR market. Young thinks the Tegsedi label is more onerous and currently models a 60% peak share to Alnylam, a 25% share to Tegsedi and 15% to future competition.
10/08/18
GSCO
10/08/18
NO CHANGE
Target $36
GSCO
Sell
Ionis' Tegsedi to face commercial headwinds, says Goldman Sachs
After the FDA approved Ionis (IONS) and affiliate Akcea Therapeutics' (AKCA) Tegsedi for adult polyneuropathy of hereditary transthyretin-mediated amyloidosis, but with a black box warning, Goldman Sachs analyst Salveen Richter said he believes the drug faces commercial headwinds. He cites the underlying safety profile and requirement for consistent monitoring as well as the recent launch of Alnylam's (ALNY) Onpattro and expected launch of Pfizer's (PFE) tafamidis in the first half of 2019. Richter keeps a Sell rating on Ionis shares with a price target of $36.

TODAY'S FREE FLY STORIES

GM

General Motors

$39.63

-0.33 (-0.83%)

18:54
02/21/19
02/21
18:54
02/21/19
18:54
Periodicals
GM CEO will not appear in front of Canada lawmakers over closure, Reuters says »

General Motors CEO Mary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

CXO

Concho Resources

$103.69

-8.68 (-7.72%)

18:37
02/21/19
02/21
18:37
02/21/19
18:37
Recommendations
Concho Resources analyst commentary  »

Concho Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

18:37
02/21/19
02/21
18:37
02/21/19
18:37
Hot Stocks
Kraft Heinz confirms quarterly dividend cut to 40c from 62.5c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

18:32
02/21/19
02/21
18:32
02/21/19
18:32
Hot Stocks
Kraft Heinz says has taken 'remedial measures' on procurement issues »

Says write down reflected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CZR

Caesars

$9.42

-0.21 (-2.18%)

18:25
02/21/19
02/21
18:25
02/21/19
18:25
Hot Stocks
Breaking Hot Stocks news story on Caesars »

Caesars: Las Vegas FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RARE

Ultragenyx

$58.16

-2.33 (-3.85%)

18:20
02/21/19
02/21
18:20
02/21/19
18:20
Initiation
Ultragenyx initiated  »

Ultragenyx resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

, CPB

Campbell Soup

$35.44

0.26 (0.74%)

18:13
02/21/19
02/21
18:13
02/21/19
18:13
Periodicals
Third Point says confident in Nestle CEO's leadership, Reuters reports »

Third Point told…

NSRGY

Nestle

$0.00

(0.00%)

CPB

Campbell Soup

$35.44

0.26 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    May

STMP

Stamps.com

$198.08

-4.03 (-1.99%)

18:11
02/21/19
02/21
18:11
02/21/19
18:11
Hot Stocks
Breaking Hot Stocks news story on Stamps.com »

Stamps.com drops 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

STMP

Stamps.com

$198.08

-4.03 (-1.99%)

18:09
02/21/19
02/21
18:09
02/21/19
18:09
Hot Stocks
Stamps.com to discontinue partnership with USPS »

On its Q4 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CZR

Caesars

$9.42

-0.21 (-2.18%)

18:08
02/21/19
02/21
18:08
02/21/19
18:08
Hot Stocks
Caesars expect modest Las Vegas revenue growth in Q1 »

Sees adverse weather…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CZR

Caesars

$9.42

-0.21 (-2.18%)

18:06
02/21/19
02/21
18:06
02/21/19
18:06
Hot Stocks
Breaking Hot Stocks news story on Caesars »

Caesars says will not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

LNT

Alliant Energy

$45.63

0.45 (1.00%)

18:03
02/21/19
02/21
18:03
02/21/19
18:03
Earnings
Breaking Earnings news story on Alliant Energy »

Alliant Energy sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

LNT

Alliant Energy

$45.63

0.45 (1.00%)

18:02
02/21/19
02/21
18:02
02/21/19
18:02
Earnings
Alliant Energy reports Q4 EPS 36c, conseensus 35c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BVN

Buenaventura

$16.53

-0.37 (-2.19%)

17:59
02/21/19
02/21
17:59
02/21/19
17:59
Earnings
Buenaventura reports Q4 EPS (29c), consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 12

    Mar

  • 12

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:58
02/21/19
02/21
17:58
02/21/19
17:58
Hot Stocks
Kraft Heinz says expects to face profit headwinds in 2019 »

Says: Expects EBITDA down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GABC

German American Bancorp

$31.59

(0.00%)

, CZFC

Citizens First

$23.30

1.87 (8.73%)

17:56
02/21/19
02/21
17:56
02/21/19
17:56
Hot Stocks
German American, Citizens First announce merger pact »

German American Bancorp,…

GABC

German American Bancorp

$31.59

(0.00%)

CZFC

Citizens First

$23.30

1.87 (8.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$291.18

-11.33 (-3.75%)

17:56
02/21/19
02/21
17:56
02/21/19
17:56
Periodicals
Lucid Motors is 'working' on an all electric SUV, Verge says »

Electric vehicle startup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

CZR

Caesars

$9.42

-0.21 (-2.18%)

17:54
02/21/19
02/21
17:54
02/21/19
17:54
Hot Stocks
Caesars sees FY19 same-store capex $375M-$450M »

Sees FY19 development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PBA

Pembina Pipeline

$36.44

-0.235 (-0.64%)

17:54
02/21/19
02/21
17:54
02/21/19
17:54
Earnings
Pembina Pipeline reports Q4 EPS C$0.66 vs C$0.83 last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:53
02/21/19
02/21
17:53
02/21/19
17:53
Hot Stocks
Kraft Heinz continues to fall, now down 16.5% to $40.25 »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CZR

Caesars

$9.42

-0.21 (-2.18%)

17:52
02/21/19
02/21
17:52
02/21/19
17:52
Hot Stocks
Caesars says in discussions with Carl Icahn after his disclosed stake »

Comments from Q4 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HRS

Harris

$164.55

-0.62 (-0.38%)

17:48
02/21/19
02/21
17:48
02/21/19
17:48
Hot Stocks
Harris awarded $168.8M Navy contract modification »

Harris has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:45
02/21/19
02/21
17:45
02/21/19
17:45
Hot Stocks
Kraft Heinz to cut quarterly dividend to 40c from 62.5c per share »

Says: Higher supply chain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HON

Honeywell

$152.60

-1.2 (-0.78%)

17:43
02/21/19
02/21
17:43
02/21/19
17:43
Hot Stocks
Honeywell awarded not-to-exceed $150M Air Force contract for ATTAM Phase 1 »

Honeywell has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

BA

Boeing

$417.48

-4.13 (-0.98%)

17:40
02/21/19
02/21
17:40
02/21/19
17:40
Hot Stocks
Tapestry awarded not-to-exceed $259M Air Force contract for WPS »

Tapestry Solutions, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.